Ballycastle, United Kingdom

John Francis Callan

This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: University of Ulster. Active years: 2022-2024.

USPTO Granted Patents = 4 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.2

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Newtownabbey, GB (2022)
  • Ballycastle Antrim, GB (2022)
  • Ballycastle, GB (2023)
  • Newtownabbey Antrim, GB (2024)

Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: John Francis Callan: Innovator in Sonodynamic Therapy

Introduction

John Francis Callan is a notable inventor based in Ballycastle, GB. He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of four patents to his name, Callan's work focuses on advanced therapeutic methods that aim to improve patient outcomes.

Latest Patents

One of Callan's latest patents is related to sonodynamic therapy. This invention involves microbubble complexes designed for use in methods of sonodynamic therapy. These complexes consist of a microbubble attached to linking groups, which are bound to at least one sonosensitizing agent and one chemotherapeutic agent. This invention is particularly effective for treating deep-sited tumors, especially pancreatic cancer. Another significant patent is the sensitizer-peptide conjugate, which is intended for cancer treatment, specifically melanoma. This conjugate comprises at least one sensitizer and one peptide, and it can be utilized in photodynamic or sonodynamic therapy.

Career Highlights

John Francis Callan is affiliated with the University of Ulster, where he continues to advance his research and innovations in cancer therapies. His work has garnered attention for its potential to revolutionize treatment methods for various types of cancer.

Collaborations

Callan has collaborated with notable colleagues, including Anthony Patrick McHale and Anthony Mchale, contributing to the development of his innovative therapies.

Conclusion

John Francis Callan's contributions to the field of cancer treatment through his patents in sonodynamic therapy and sensitizer-peptide conjugates highlight his role as a leading inventor. His work continues to pave the way for advancements in medical technology and cancer treatment.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…